Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 220

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

The role of dietary fatty acids in the pathology of metabolic syndrome

Lottenberg, Ana Maria, Afonso, Milessa da Silva, Lavrador, Maria Silvia Ferrari, Machado, Roberta Marcondes, Nakandakare, Edna Regina·2012·The Journal of Nutritional Biochemistry

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jnutbio.2012.03.004

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Research works printed but not linked: 147

  1. Ford, 2005, Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence, Diabetes Care, 28, 1769, 10.2337/diacare.28.7.1769 · DOI · Paper page
  2. Rioux, 2007, Saturated fatty acids: simple molecular structures with complex cellular functions, Curr Opin Clin Nutr Metab Care, 10, 752
  3. Kris-Etherton, 1997, Individual fatty acid effects on plasma lipids and lipoproteins: human studies, Am J Clin Nutr, 65, 1628S, 10.1093/ajcn/65.5.1628S · DOI · Paper page
  4. Chappell, 1993, Low density lipoprotein receptors bind and mediate cellular catabolism of normal very low density lipoproteins in vitro, J Biol Chem, 268, 25487, 10.1016/S0021-9258(19)74418-4 · DOI
  5. Daumerie, 1992, Fatty acids regulate hepatic low density lipoprotein receptor activity through redistribution of intracellular cholesterol pools, Proc Natl Acad Sci U S A, 89, 10797, 10.1073/pnas.89.22.10797 · DOI
  6. Nicolosi, 1990, Effect of dietary fat saturation and cholesterol on LDL composition and metabolism, Arteriosclerosis, 10, 119, 10.1161/01.ATV.10.1.119 · DOI
  7. Lee, 2004, Dietary fatty acids regulate acyl-CoA: cholesterol acyltransferase and cytosolic cholesteryl ester hydrolase in hamsters, J Nutr, 134, 3239, 10.1093/jn/134.12.3239 · DOI
  8. Jackson, 2006, Saturated fat-induced changes in Sf 60-400 particle composition reduces uptake of LDL by HepG2 cells, J Lipid Res, 47, 393, 10.1194/jlr.M500382-JLR200 · DOI
  9. Spritz, 1969, Effects of dietary fats on plasma lipids and lipoproteins: an hypothesis for the lipid-lowering effect of unsaturated fatty acids, J Clin Invest, 48, 78, 10.1172/JCI105976 · DOI · Paper page
  10. Kris-Etherton, 2005, Dietary stearic acid and risk of cardiovascular disease: intake, sources, digestion, and absorption, Lipids, 40, 1193, 10.1007/s11745-005-1485-y · DOI
  11. Guillou, 2010, The key roles of elongases in mammalian fatty acid metabolism: insights from transgenic mice, Prog Lipid Res, 49, 186, 10.1016/j.plipres.2009.12.002 · DOI · Paper page
  12. Rioux, 2000, Myristic acid, unlike palmitic acid, is rapidly metabolized in cultured rat hepatocytes, J Nutr Biochem, 11, 198, 10.1016/S0955-2863(00)00065-6 · doi:10.1016/s0955-2863(00)00065-6
  13. Nestel, 2008, Effects of dairy fats within different foods on plasma lipids, J Am Coll Nutr, 27, 735S, 10.1080/07315724.2008.10719751 · DOI
  14. Rioux, 2011, Regulation of mammalian desaturases by myristic acid: N-terminal myristoylation and other modulations, Biochim Biophys Acta, 1811, 1, 10.1016/j.bbalip.2010.09.005 · DOI
  15. de Wildt, 1984, Influence of dietary rapeseed oil and erucic acid upon myocardial performance and hemodynamics in rats, Toxicol Appl Pharmacol, 74, 99, 10.1016/0041-008X(84)90275-8 · doi:10.1016/0041-008x(84)90275-8
  16. Tripodi, 1991, Effect of fish oil and coconut oil diet on the LDL receptor activity of rat liver plasma membranes, Biochim Biophys Acta, 1083, 298, 10.1016/0005-2760(91)90086-W · DOI
  17. Fernandez, 1989, Dietary fat-mediated changes in hepatic apoprotein B/E receptor in the guinea pig: effect of polyunsaturated, monounsaturated, and saturated fat, Metabolism, 38, 1094, 10.1016/0026-0495(89)90046-2 · DOI
  18. Yu-Poth, 2005, Long-chain polyunsaturated fatty acids upregulate LDL receptor protein expression in fibroblasts and HepG2 cells, J Nutr, 135, 2541, 10.1093/jn/135.11.2541 · DOI
  19. Shepherd, 1980, Sequential changes in plasma lipoproteins and body fat composition during polyunsaturated fat feeding in man, Br J Nutr, 44, 265, 10.1079/BJN19800040 · doi:10.1079/bjn19800040
  20. Johnson, 1985, St Clair RW, Rudel LL. Effects of the degree of saturation of dietary fat on the hepatic production of lipoproteins in the African green monkey, J Lipid Res, 26, 403, 10.1016/S0022-2275(20)34354-6 · DOI
  21. Lottenberg, 1996, Plasma cholesteryl ester synthesis, cholesteryl ester transfer protein concentration and activity in hypercholesterolemic women: effects of the degree of saturation of dietary fatty acids in the fasting and postprandial states, Atherosclerosis, 126, 265, 10.1016/0021-9150(96)05914-X · DOI
  22. Uehara, 2007, Unsaturated fatty acids suppress the expression of the ATP-binding cassette transporter G1 (ABCG1) and ABCA1 genes via an LXR/RXR responsive element, Atherosclerosis, 191, 11, 10.1016/j.atherosclerosis.2006.04.018 · DOI
  23. Lichtenstein, 1994, Hypercholesterolemic effect of dietary cholesterol in diets enriched in polyunsaturated and saturated fat, Arterioscler Thromb, 14, 168, 10.1161/01.ATV.14.1.168 · DOI
  24. Louheranta, 1996, Linoleic acid intake and susceptibility of very-low-density and low-density lipoproteins to oxidation in men, Am J Clin Nutr, 63, 698, 10.1093/ajcn/63.5.698 · DOI
  25. Rajamoorthi, 2005, Packing and viscoelasticity of polyunsaturated omega-3 and omega-6 lipid bilayers as seen by (2)H NMR and X-ray diffraction, J Am Chem Soc, 127, 1576, 10.1021/ja046453b · DOI
  26. Rustan, 1988, Eicosapentaenoic acid reduces hepatic synthesis and secretion of triacylglycerol by decreasing the activity of acylcoenzyme A: 1,2-diacylglycerolacyltransferase, J Lipid Res, 29, 1417, 10.1016/S0022-2275(20)38418-2 · DOI · Paper page
  27. Lottenberg, 1992, Effect of dietary fish oil on the rate of very low density lipoprotein triacylglycerol formation and on the metabolism of chylomicrons, Lipids, 27, 326, 10.1007/BF02536145 · DOI
  28. Davidson, 2006, Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids, Am J Cardiol, 98, 27, 10.1016/j.amjcard.2005.12.024 · DOI · Paper page
  29. Sampath, 2005, Polyunsaturated fatty acid regulation of genes of lipid metabolism, Annu Rev Nutr, 25, 317, 10.1146/annurev.nutr.25.051804.101917 · DOI · Paper page
  30. Rodriguez-Cruz, 2005, Molecular mechanisms of action and health benefits of polyunsaturated fatty acids, Rev Invest Clin, 57, 457
  31. de Lorgeril, 1999, Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study, Circulation, 99, 779, 10.1161/01.CIR.99.6.779 · DOI · Paper page
  32. Balk, 2006, Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review, Atherosclerosis, 189, 19, 10.1016/j.atherosclerosis.2006.02.012 · DOI · Paper page
  33. Reaven, 1994, Effect of linoleate-enriched and oleate-enriched diets in combination with alpha-tocopherol on the susceptibility of LDL and LDL subfractions to oxidative modification in humans, Arterioscler Thromb, 14, 557, 10.1161/01.ATV.14.4.557 · DOI · Paper page
  34. Grundy, 1991, Multifactorial etiology of hypercholesterolemia. Implications for prevention of coronary heart disease, Arterioscler Thromb, 11, 1619, 10.1161/01.ATV.11.6.1619 · DOI
  35. Jones, 1994, Effect of dietary fat selection on plasma cholesterol synthesis in older, moderately hypercholesterolemic humans, Arterioscl Thromb, 14, 542, 10.1161/01.ATV.14.4.542 · doi:10.1161/01.atv.14.4.542
  36. Pérez-Martínez, 2011, Mediterranean diet rich in olive oil and obesity, metabolic syndrome and diabetes mellitus, Curr Pharm Des, 17, 769, 10.2174/138161211795428948 · DOI · Paper page
  37. Gillingham, 2011, Dietary monounsaturated fatty acids are protective against metabolic syndrome and cardiovascular disease risk factors, Lipids, 46, 209, 10.1007/s11745-010-3524-y · DOI · Paper page
  38. Esposito, 2008, Mediterranean dietary patterns and chronic diseases, Am J Clin Nutr, 88, 1179, 10.1093/ajcn/88.4.1179 · DOI
  39. Sommerfeld, 1983, Trans unsaturated fatty acids in natural products and processed foods, Prog Lipid Res, 22, 221, 10.1016/0163-7827(83)90010-3 · DOI
  40. Matthan, 2004, Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women, Arterioscler Thromb Vasc Biol, 24, 1092, 10.1161/01.ATV.0000128410.23161.be · DOI
  41. Buonacorso, 2007, Macrophage cholesterol efflux elicited by human total plasma and by HDL subfractions is not affected by different types of dietary fatty acids, Am J Clin Nutr, 86, 1270, 10.1093/ajcn/86.5.1270 · DOI
  42. Matthan, 2001, Hydrogenated fat consumption affects acylation-stimulating protein levels and cholesterol esterification rates in moderately hypercholesterolemic women, J Lipid Res, 42, 1841, 10.1016/S0022-2275(20)31510-8 · DOI
  43. Zapolska-Downar, 2005, Trans fatty acids induce apoptosis in human endothelial cells, J Physiol Pharmacol, 56, 611
  44. Eckel, 2007, Understanding the complexity of trans fatty acid reduction in the American diet: American Heart Association Trans Fat Conference 2006: report of the Trans Fat Conference Planning Group, Circulation, 115, 2231, 10.1161/CIRCULATIONAHA.106.181947 · DOI · Paper page
  45. Berry, 2009, Triacylglycerol structure and interesterification of palmitic and stearic acid-rich fats: an overview and implications for cardiovascular disease, Nutr Res Rev, 22, 3, 10.1017/S0954422409369267 · DOI · Paper page
  46. Hayes, 2001, Synthetic and modified glycerides: effects on plasma lipids, Curr Opin Lipidol, 12, 55, 10.1097/00041433-200102000-00010 · DOI
  47. Wang, 1982, Studies of the substrate specificity of purified human milk lipoprotein lipase, Lipids, 17, 278, 10.1007/BF02534942 · doi:10.1007/bf02534942
  48. Sundram, 2007, Stearic acid-rich interesterified fat and trans-rich fat raise the LDL/HDL ratio and plasma glucose relative to palm olein in humans, Nutr Metab, 4, 3, 10.1186/1743-7075-4-3 · DOI
  49. Nestel, 1995, Effect on plasma lipids of interesterifying a mix edible oils, Am J Clin Nutr, 62, 950, 10.1093/ajcn/62.5.950 · DOI
  50. Meijer, 1997, Interesterification of fats in margarine: effect on blood lipids, blood enzymes, and hemostasis parameters, Eur J Clin Nutr, 51, 527, 10.1038/sj.ejcn.1600437 · DOI
  51. Robinson, 2009, Influence of interesterification of a stearic acid-rich spreadable fat on acute metabolic risk factors, Lipids, 44, 17, 10.1007/s11745-008-3253-7 · DOI
  52. Serfaty, 2008, Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis, Diabetes Metab, 34, 634, 10.1016/S1262-3636(08)74597-X · DOI
  53. Targher, 2008, Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients, Diabetologia, 51, 444, 10.1007/s00125-007-0897-4 · DOI · Paper page
  54. Daly, 2011, Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease, Expert Rev Gastroenterol Hepatol, 5, 253, 10.1586/egh.11.18 · DOI
  55. Westerbacka, 2005, Dietary fat content modifies liver fat in overweight nondiabetic subjects, J Clin Endocrinol Metab, 90, 2804, 10.1210/jc.2004-1983 · DOI · Paper page
  56. Machado, 2010, Intake of trans fatty acids causes nonalcoholic steatohepatitis and reduces adipose tissue fat content, J Nutr, 140, 1127, 10.3945/jn.109.117937 · DOI
  57. Meijer, 2010, Dietary fat intake promotes the development of hepatic steatosis independently from excess caloric consumption in a murine model, Metabolism, 59, 1092, 10.1016/j.metabol.2009.11.006 · DOI
  58. Targher, 2007, Non-alcoholic fatty liver disease and increased risk of cardiovascular disease, Atherosclerosis, 191, 235, 10.1016/j.atherosclerosis.2006.08.021 · DOI · Paper page
  59. Buse, 2007, American Heart Association; American Diabetes Association. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association, Circulation, 115, 114, 10.1161/CIRCULATIONAHA.106.179294 · DOI · Paper page
  60. Kolak, 2007, Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity, Diabetes, 56, 1960, 10.2337/db07-0111 · DOI · Paper page
  61. Westerbacka, 2007, Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects, Diabetes, 56, 2759, 10.2337/db07-0156 · DOI · Paper page
  62. Casaschi, 2005, Increased diacylglycerol acyltransferase activity is associated with triglyceride accumulation in tissues of diet-induced insulin-resistant hyperlipidemic hamsters, Metabolism, 54, 403, 10.1016/j.metabol.2004.09.016 · DOI
  63. Wang, 2006, Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis, Endocrinology, 147, 943, 10.1210/en.2005-0570 · DOI · Paper page
  64. Malhi, 2006, Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis, J Biol Chem, 281, 12093, 10.1074/jbc.M510660200 · DOI · Paper page
  65. Lin, 2005, Hyperlipidemic effects of dietary saturated fats mediated through PGC-1 coactivation of SREBP, Cell, 120, 261, 10.1016/j.cell.2004.11.043 · DOI · Paper page
  66. Sampath, 2007, Stearoyl-CoA desaturase-1 mediates the prolipogenic effects of dietary saturated fat, J Biol Chem, 282, 2483, 10.1074/jbc.M610158200 · DOI · Paper page
  67. Oosterveer, 2009, High fat feeding induces hepatic fatty acid elongation in mice, PLoS One, 4, e6066, 10.1371/journal.pone.0006066 · DOI
  68. Inoue, 2005, Increased expression of PPARγ in high fat diet-induced liver steatosis in mice, Biochem Biophys Res Commun, 336, 215, 10.1016/j.bbrc.2005.08.070 · DOI · Paper page
  69. Ren, 1997, Polyunsaturated fatty acid suppression of hepatic fatty acid synthase and S14 gene expression does not require peroxisome proliferator-activated receptor, J Biol Chem, 272, 26827, 10.1074/jbc.272.43.26827 · DOI · Paper page
  70. Jump, 2011, Fatty acid regulation of hepatic lipid metabolism, Curr Opin Clin Nutr Metab Care, 14, 115
  71. Yoshikawa, 2002, Polyunsaturated fatty acids suppress sterol regulatory element binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements, J Biol Chem, 277, 1705, 10.1074/jbc.M105711200 · DOI · Paper page
  72. Pawar, 2002, Fatty acid regulation of liver X receptors (LXR) and peroxisome proliferator-activated receptor alpha (PPARalpha) in HEK293 cells, J Biol Chem, 277, 39243, 10.1074/jbc.M206170200 · DOI
  73. Howell, 2009, N-3 polyunsaturated fatty acids suppress insulin-induced SREBP-1c transcription via reduced transactivating capacity if LXR, Biochim Biophys Acta, 1791, 1190, 10.1016/j.bbalip.2009.08.008 · DOI
  74. Levin, 2005, Macrophage liver X receptor is required for antiatherogenic activity of LXR agonists, Arterioscler Thromb Vasc Biol, 25, 135, 10.1161/01.ATV.0000150044.84012.68 · DOI · Paper page
  75. Cha, 2007, The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR, J Biol Chem, 282, 743, 10.1074/jbc.M605023200 · DOI · Paper page
  76. Duplus, 2002, Is there a single mechanism for fatty acid regulation of gene transcription?, Biochem Pharmacol, 64, 893, 10.1016/S0006-2952(02)01157-7 · DOI · Paper page
  77. Zhao, 2004, Polyunsaturated fatty acids are FXR ligands and differentially regulate expression of FXR targets, DNA Cell Biol, 23, 519, 10.1089/1044549041562267 · DOI
  78. Duran-Sandoval, 2005, The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition, J Biol Chem, 280, 29971, 10.1074/jbc.M501931200 · DOI · Paper page
  79. Pineda Torra, 2003, Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor, Mol Endocrinol, 17, 259, 10.1210/me.2002-0120 · DOI · Paper page
  80. Sinal, 2000, Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis, Cell, 102, 731, 10.1016/S0092-8674(00)00062-3 · DOI · Paper page
  81. Landschulz, 1994, Transcriptional control of the stearoyl-CoA desaturase-1 gene by polyunsaturated fatty acids, Biochem Biophys Res Comm, 200, 763, 10.1006/bbrc.1994.1516 · DOI
  82. Kohan, 2011, Chylomicron remnants and nonesterified fatty acids differ in their ability to inhibit genes involved in lipogenesis in rats, J Nutr, 141, 171, 10.3945/jn.110.129106 · DOI
  83. Uyeda, 2006, Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis, Cell Metab, 4, 107, 10.1016/j.cmet.2006.06.008 · DOI · Paper page
  84. Postic, 2007, ChREBP, a transcriptional regulator of glucose and lipid metabolism, Annu Rev Nutr, 27, 179, 10.1146/annurev.nutr.27.061406.093618 · DOI · Paper page
  85. Denechaud, 2007, Role of ChREBP in hepatic steatosis and insulin resistance, FEBS Lett, 582, 68, 10.1016/j.febslet.2007.07.084 · DOI · Paper page
  86. Uyeda, 2002, Carbohydrate responsive element-binding protein (ChREBP): a key regulator of glucose metabolism and fat storage, Biochem Pharmacol, 63, 2075, 10.1016/S0006-2952(02)01012-2 · DOI · Paper page
  87. Stabile, 1996, Posttranscriptional regulation of glucose-6-phosphate dehydrogenase by dietary polyunsaturated fat, Arch Biochem Biophys, 332, 269, 10.1006/abbi.1996.0342 · DOI
  88. Talukdar, 2005, Arachidonic acid inhibits the insulin induction of glucose-6-phosphate dehydrogenase via p38 MAP Kinase, J Biol Chem, 280, 40660, 10.1074/jbc.M505531200 · DOI
  89. Hertz, 1998, Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4alpha, Nature, 392, 512, 10.1038/33185 · DOI · Paper page
  90. Rajas, 2002, Polyunsaturated fatty acyl coenzyme a suppress the glucose-6-phosphatase promoter activity by modulating the DNA binding of hepatocyte nuclear factor 4α, J Biol Chem, 277, 15736, 10.1074/jbc.M200971200 · DOI
  91. Dorfman, 2006, Dietary fatty acids differentially modulate messenger RNA abundance of low-density lipoprotein receptor, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and microsomal triglyceride transfer protein in Golden-Syrian hamsters, Metabolism, 55, 635, 10.1016/j.metabol.2005.12.005 · DOI
  92. Pan, 2004, Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production, J Clin Invest, 113, 1277, 10.1172/JCI19197 · DOI · Paper page
  93. Caviglia, 2011, Different fatty acids inhibit apoB100 secretion by different pathways: unique roles for ER stress, ceramide, and autophagy, J Lipid Res, 52, 1636, 10.1194/jlr.M016931 · DOI
  94. López-Soldado, 2009, Suppression of VLDL secretion by cultured hepatocytes incubated with chylomicron remnants enriched in n-3 polyunsaturated fatty acids is regulated by hepatic nuclear factor-4alpha, Biochim Biophys Acta, 1791, 1181, 10.1016/j.bbalip.2009.08.004 · DOI
  95. Pettinelli, 2009, Enhancement in liver SREBP-1c/PPAR-alpha ratio and statuses in obese patients: correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion, Biochim Biophys Acta, 1792, 1080, 10.1016/j.bbadis.2009.08.015 · DOI · Paper page
  96. Marsman, 2011, Reversal of hepatic steatosis by omega-3 fatty acids measured non-invasively by (1) H-magnetic resonance spectroscopy in a rat model, J Gastroenterol Hepatol, 26, 356, 10.1111/j.1440-1746.2010.06326.x · DOI
  97. Man, 2006, Colocalization of SCD1 and DGAT2: implying preference for endogenous monounsaturated fatty acids in triglyceride synthesis, J Lipid Res, 47, 1928, 10.1194/jlr.M600172-JLR200 · DOI · Paper page
  98. Assy, 2009, Olive oil consumption and non-alcoholic fatty liver disease, World J Gastroenterol, 15, 1809, 10.3748/wjg.15.1809 · DOI · Paper page
  99. Sato, 2007, Dietary palatinose and oleic acid ameliorate disorders of glucose and lipid metabolism in Zucker fatty rats, J Nutr, 137, 1908, 10.1093/jn/137.8.1908 · DOI
  100. Hussein, 2007, Monounsaturated fat decreases hepatic lipid content in non-alcoholic fatty liver disease in rats, World J Gastroenterol, 13, 361, 10.3748/wjg.v13.i3.361 · DOI
  101. Buettner, 2006, Defining high-fat-diet rat models: metabolic and molecular effects of different fat types, J Mol Endocrinol, 36, 485, 10.1677/jme.1.01909 · DOI · Paper page
  102. Rector, 2008, Non-alcoholic fatty liver disease and the metabolic syndrome: an update, World J Gastroenterol, 14, 185, 10.3748/wjg.14.185 · DOI · Paper page
  103. Sookoian, 2008, Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review, J Hepatol, 49, 600, 10.1016/j.jhep.2008.06.012 · DOI · Paper page
  104. Cassagno, 2005, Low amounts of trans 18:1 fatty acids elevate plasma triacylglycerols but not cholesterol and alter the cellular defense to oxidative stress in mice, Br J Nutr, 94, 346, 10.1079/BJN20051512 · DOI
  105. Obara, 2010, Possible involvement and the mechanisms of excess trans-fatty acid consumption in severe NAFLD in mice, J Hepatol, 53, 326, 10.1016/j.jhep.2010.02.029 · DOI
  106. Fernández-Quintela, 2007, The role of dietary fat in adipose tissue metabolism, Public Health Nutr, 10, 1126, 10.1017/S1368980007000602 · DOI
  107. Coenen, 2007, Diet-induced increases in adiposity, but not plasma lipids, promote macrophage infiltration into white adipose tissue, Diabetes, 56, 564, 10.2337/db06-1375 · DOI
  108. Boden, 2002, Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β-cell dysfunction, Eur J Clin Invest, 32, 14, 10.1046/j.1365-2362.32.s3.3.x · DOI · Paper page
  109. Schaffer, 2003, Lipotoxicity: when tissues overeat, Curr Opin Lipidol, 14, 281, 10.1097/00041433-200306000-00008 · DOI · Paper page
  110. Ibrahim, 2005, Ghafoorunissa. Dietary trans-fatty acids alter adipocyte plasma membrane fatty acid composition and insulin sensitivity in rats, Metabolism, 54, 240, 10.1016/j.metabol.2004.08.019 · DOI
  111. Elmendorf, 2004, Fluidity of insulin action, Mol Biotechnol, 27, 127, 10.1385/MB:27:2:127 · DOI
  112. Nugent, 2001, Arachidonic acid stimulates glucose uptake in 3T3-L1 adipocytes by increasing GLUT1 and GLUT4 levels at the plasma membrane. Evidence for involvement of lipoxygenase metabolites and peroxisome proliferator-activated receptor gamma, J Biol Chem, 276, 9149, 10.1074/jbc.M009817200 · DOI
  113. Saravanan, 2005, Differential effects of dietary saturated and trans-fatty acids on expression of genes associated with insulin sensitivity in rat adipose tissue, Eur J Endocrinol, 153, 159, 10.1530/eje.1.01946 · DOI
  114. Manickam, 2010, Suppressive actions of eicosapentaenoic acid on lipid droplet formation in 3T3-L1 adipocytes, Lipids Health Dis, 9, 57, 10.1186/1476-511X-9-57 · DOI
  115. Nicolas, 1991, Dietary (n-6) polyunsaturated fatty acids affect β-adrenergic receptor binding and adenylate cyclase activity in pig adipocyte plasma membrane, J Nutr, 121, 1179, 10.1093/jn/121.8.1179 · DOI
  116. Fickova, 1998, Dietary (n-3) and (n-6) polyunsaturated fatty acids rapidly modify fatty acid composition and insulin effects in rat adipocytes, J Nutr, 128, 512, 10.1093/jn/128.3.512 · DOI
  117. Mustad, 2006, Differential effects of n-3 polyunsaturated fatty acids on metabolic control and vascular reactivity in the type 2 diabetic ob/ob mouse, Metabolism, 55, 1365, 10.1016/j.metabol.2006.06.007 · DOI
  118. Hartweg, 2009, Potential impact of omega-3 treatment on cardiovascular disease in type 2 diabetes, Curr Opin Lipidol, 20, 30, 10.1097/MOL.0b013e328321b3be · DOI
  119. Djoussé, 2011, Dietary omega-3 fatty acids and fish consumption and risk of type 2 diabetes, Am J Clin Nutr, 93, 143, 10.3945/ajcn.110.005603 · DOI · Paper page
  120. Long, 1996, Regulation of GLUT4 gene expression by arachidonic acid. Evidence for multiple pathways, one of which requires oxidation to prostaglandin E2, J Biol Chem, 271, 1138, 10.1074/jbc.271.2.1138 · DOI
  121. Tebbey, 1994, Arachidonic acid down-regulates the insulin-dependent glucose transporter gene (GLUT4) in 3T3-L1 adipocytes by inhibiting transcription and enhancing mRNA turnover, J Biol Chem, 269, 639, 10.1016/S0021-9258(17)42397-0 · DOI
  122. Sauma, 2006, PPAR-gamma response element activity in intact primary human adipocytes: effects of fatty acids, Nutrition, 22, 60, 10.1016/j.nut.2005.04.011 · DOI
  123. Tontonoz, 1994, mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer, Genes Dev, 8, 1224, 10.1101/gad.8.10.1224 · DOI · Paper page
  124. Oster, 2010, Docosahexaenoic acid increases cellular adiponectin mRNA and secreted adiponectin protein, as well as PPARγ mRNA, in 3T3-L1 adipocytes, Appl Physiol Nutr Metab, 35, 783, 10.1139/H10-076 · DOI
  125. Mozaffarian, 2004, Dietary intake of trans fatty acids and systemic inflammation in women, Am J Clin Nutr, 79, 606, 10.1093/ajcn/79.4.606 · DOI · Paper page
  126. Chambrier, 2002, Eicosapentaenoic acid induces mRNA expression of peroxisome proliferator-activated receptor gamma, Obes Res, 10, 518, 10.1038/oby.2002.70 · DOI
  127. Forman, 1995, 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma, Cell, 83, 803, 10.1016/0092-8674(95)90193-0 · DOI · Paper page
  128. Stewart, 1999, 11β-hydroxysteroid dehydrogenase, Vitam Horm, 57, 249, 10.1016/S0083-6729(08)60646-9 · DOI · Paper page
  129. Prasad, 2010, A novel genetically-obese rat model with elevated 11 beta-hydroxysteroid dehydrogenase type 1 activity in subcutaneous adipose tissue, Lipids Health Dis, 9, 132, 10.1186/1476-511X-9-132 · DOI
  130. Berger, 2001, Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta -hydroxysteroid dehydrogenase type 1 expression and activity, J Biol Chem, 276, 12629, 10.1074/jbc.M003592200 · DOI · Paper page
  131. Mater, 1998, Arachidonic acid inhibits lipogenic gene expression in 3T3-L1 adipocytes through a prostanoid pathway, J Lipid Res, 39, 1327, 10.1016/S0022-2275(20)32513-X · DOI
  132. Brown, 2010, Stearoyl-coenzyme A desaturase 1 inhibition and the metabolic syndrome: considerations for future drug discovery, Curr Opin Lipidol, 21, 192, 10.1097/MOL.0b013e32833854ac · DOI
  133. Sessler, 1996, Regulation of stearoyl-CoA desaturase 1 mRNA stability by polyunsaturated fatty acids in 3T3-L1 adipocytes, J Biol Chem, 271, 29854, 10.1074/jbc.271.47.29854 · DOI
  134. Hotamisligil, 2005, Role of endoplasmic reticulum stress and c-Jun NH2-terminal kinase pathways in inflammation and origin of obesity and diabetes, Diabetes, 54, S73, 10.2337/diabetes.54.suppl_2.S73 · DOI · Paper page
  135. Nappo, 2002, Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals, J Am Coll Cardiol, 39, 1145, 10.1016/S0735-1097(02)01741-2 · DOI · Paper page
  136. Bradley, 2008, Dietary fatty acids differentially regulate production of TNF-α and IL-10 by murine 3T3-L1 adipocytes, Obesity, 16, 938, 10.1038/oby.2008.39 · DOI · Paper page
  137. Baer, 2004, Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized cross over study, Am J Clin Nutr, 79, 969, 10.1093/ajcn/79.6.969 · DOI · Paper page
  138. Suganami, 2007, Role of the toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages, Arterioscler Thromb Vasc Biol, 27, 84, 10.1161/01.ATV.0000251608.09329.9a · DOI · Paper page
  139. Youssef-Elabd, 2011, Acute and chronic saturated fatty acid treatment as a key instigator of the TLR-mediated inflammatory response in human adipose tissue, in vitro, J Nutr Biochem
  140. Rasouli, 2008, Adipocytokines and the metabolic complications of obesity, J Clin Endocrinol Metab, 93, S64, 10.1210/jc.2008-1613 · DOI · Paper page
  141. Qatanani, 2009, Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice, J Clin Invest, 119, 531, 10.1172/JCI37273 · DOI · Paper page
  142. Granados, 2011, Distinct effects of oleic acid and its trans-isomer elaidic acid on the expression of myokines and adipokines in cell models, Br J Nutr, 105, 1226, 10.1017/S0007114510004885 · DOI
  143. Flachs, 2006, Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet, Diabetologia, 49, 394, 10.1007/s00125-005-0053-y · DOI · Paper page
  144. James, 2000, Dietary polyunsaturated fatty acids and inflammatory mediator production, Am J Clin Nutr, 71, 343S, 10.1093/ajcn/71.1.343S · DOI · Paper page
  145. Fleming, 2011, Cytochrome P450-dependent eicosanoid production and crosstalk, Curr Opin Lipidol, 22, 403, 10.1097/MOL.0b013e32834a9790 · DOI
  146. Spector, 2009, Arachidonic acid cytochrome P450 epoxygenase pathway, J Lipid Res, 50, S52, 10.1194/jlr.R800038-JLR200 · DOI · Paper page
  147. Mozaffarian, 2005, Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men, Circulation, 111, 157, 10.1161/01.CIR.0000152099.87287.83 · DOI · Paper page

Cited by

See all 220

Metadata

Authors
Lottenberg, A. M., Afonso, M. D. S., Lavrador, M. S. F., Machado, R. M., & Nakandakare, E. R.
Venue
The Journal of Nutritional Biochemistry
Publisher
Elsevier BV
Published
2012-09
Volume
23
Issue
9
Pages
1027-1040
ISSN
0955-2863 (ISSN-L)
OpenAlex
W2163591544
Cited by
220
References
26
FWCI
18.95
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The role of dietary fatty acids in the pathology of metabolic syndrome. https://app.cochat.ai/papers/10.1016/j.jnutbio.2012.03.004
The paper
Lottenberg, A. M., Afonso, M. D. S., Lavrador, M. S. F., Machado, R. M., & Nakandakare, E. R. (2012). The role of dietary fatty acids in the pathology of metabolic syndrome. The Journal of Nutritional Biochemistry. https://doi.org/10.1016/j.jnutbio.2012.03.004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.